March 11, 2020
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement regarding today’s announcement from the Centers for Medicare and Medicaid Services’ “Part D Senior Savings Model” for insulin:
“While we are still reviewing the details of the Part D Senior Savings Model, we commend the Administration for taking action to lower insulin costs for America’s Medicare beneficiaries.
Pharmacy benefit managers (PBMs) are already innovating to reduce financial barriers for patients. In fact, a PBM-led private-sector program is currently available that lowers patients’ monthly out-of-pocket costs by 40% or more, while another PBM initiative provides access to diabetes drugs, including insulin, at no cost to enrollees.
We look forward to working with the Administration on solutions to help every patient affordably access needed prescription drugs, including solutions that address manufacturer pricing and patent policies.”